Hemas Holdings Plc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: LK0337N00002
LKR
36.50
6.9 (23.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,17,970.17
1,21,613.77
1,13,939.57
78,830.85
64,500.75
60,043.49
64,082.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,17,970.17
1,21,613.77
1,13,939.57
78,830.85
64,500.75
60,043.49
64,082.15
Raw Material Cost
80,896.88
85,616.54
82,146.71
56,981.19
45,084.04
40,895.81
43,554.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
13,048.30
11,941.49
9,865.85
7,729.23
7,118.59
7,770.76
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,500.39
3,254.62
4,107.76
633.40
640.13
981.66
1,044.43
Selling and Distribution Expenses
24,910.71
24,923.83
21,149.62
15,640.76
13,704.19
15,994.31
15,506.79
Other Expenses
-1,454.87
-1,519.61
-1,397.36
-836.26
-775.87
-875.24
-104.44
Total Expenditure (Excl Depreciation)
1,05,807.60
1,10,540.37
1,03,296.34
72,621.94
58,788.23
56,890.12
59,060.93
Operating Profit (PBDIT) excl Other Income
12162.6
11073.4
10643.199999999999
6208.9
5712.5
3153.3999999999996
5021.2
Other Income
1,278.57
1,290.75
1,421.77
1,439.68
867.96
914.09
976.23
Operating Profit (PBDIT)
15,438.83
14,047.10
13,667.45
9,109.93
6,580.48
4,067.46
7,356.91
Interest
1,500.39
3,254.62
4,107.76
633.40
640.13
981.66
1,044.43
Exceptional Items
336.24
264.97
207.89
158.06
62.91
-125.12
140.12
Gross Profit (PBDT)
37,073.29
35,997.23
31,792.86
21,849.66
19,416.71
19,147.68
20,528.01
Depreciation
1,997.68
1,682.95
1,602.44
1,461.35
0.00
0.00
1,359.46
Profit Before Tax
12,277.00
9,374.50
8,165.14
7,173.24
6,003.25
2,960.68
5,093.14
Tax
4,390.14
3,113.34
2,696.32
1,813.71
1,523.05
1,356.71
1,413.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
8,056.96
6,108.52
4,268.85
4,248.55
4,058.18
1,357.03
3,369.28
Extraordinary Items
0.00
0.00
0.00
0.00
-0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
8,056.96
6,108.52
4,268.85
4,248.55
4,058.18
1,357.03
3,369.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
281.70
246.13
799.83
585.91
88.68
126.99
309.96
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8,338.66
6,354.65
5,068.68
4,834.47
4,146.86
1,484.02
3,679.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
49,780.39
43,431.77
38,404.56
35,587.79
31,895.38
27,914.29
28,098.64
Earnings per share (EPS)
2.7
2.05
1.43
1.42
1.22
0.41
1.13
Diluted Earnings per share
2.7
2.05
1.43
1.42
1.22
0.41
1.13
Operating Profit Margin (Excl OI)
10.31%
9.11%
9.34%
7.88%
8.86%
5.25%
7.84%
Gross Profit Margin
12.1%
9.09%
8.57%
10.95%
9.31%
4.93%
10.07%
PAT Margin
6.83%
5.02%
3.75%
5.39%
6.29%
2.26%
5.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 11.01% vs 4.17% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -53.90% vs -20.77% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Hemas Holdings Plc With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(LKR)
Change(%)
Net Sales
1,17,970.17
3,17,377.73
-1,99,407.56
-62.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,17,970.17
3,17,377.73
-1,99,407.56
-62.83%
Raw Material Cost
80,896.88
2,53,847.02
-1,72,950.14
-68.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
13,048.30
31,932.11
-18,883.81
-59.14%
Power Cost
0
0
0.00
Manufacturing Expenses
1,500.39
18,442.65
-16,942.26
-91.86%
Selling and Distribution Expenses
24,910.71
45,528.63
-20,617.92
-45.29%
Other Expenses
-1,454.87
-5,037.48
3,582.61
71.12%
Total Expenditure (Excl Depreciation)
1,05,807.60
2,99,375.66
-1,93,568.06
-64.66%
Operating Profit (PBDIT) excl Other Income
12,162.58
18,002.07
-5,839.49
-32.44%
Other Income
1,278.57
2,372.61
-1,094.04
-46.11%
Operating Profit (PBDIT)
15,438.83
37,050.85
-21,612.02
-58.33%
Interest
1,500.39
18,442.65
-16,942.26
-91.86%
Exceptional Items
336.24
2,170.36
-1,834.12
-84.51%
Gross Profit (PBDT)
37,073.29
63,530.70
-26,457.41
-41.65%
Depreciation
1,997.68
16,676.18
-14,678.50
-88.02%
Profit Before Tax
12,277.00
4,102.38
8,174.62
199.27%
Tax
4,390.14
7,957.07
-3,566.93
-44.83%
Provisions and contingencies
0
0
0.00
Profit After Tax
8,056.96
5,326.37
2,730.59
51.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
8,056.96
5,326.37
2,730.59
51.27%
Share in Profit of Associates
0
0
0.00
Minority Interest
281.70
1,597.89
-1,316.19
-82.37%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8,338.66
6,924.26
1,414.40
20.43%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
49,780.39
3,99,078.43
-3,49,298.04
-87.53%
Earnings per share (EPS)
2.70
0.32
2.38
743.75%
Diluted Earnings per share
2.70
0.32
2.38
743.75%
Operating Profit Margin (Excl OI)
10.31%
5.67%
0.00
4.64%
Gross Profit Margin
12.10%
6.55%
0.00
5.55%
PAT Margin
6.83%
1.68%
0.00
5.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 11,797.02 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 833.87 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,416.03 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 11.01% vs 4.17% in Mar 2024

Annual - Interest
Interest 150.04 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -53.90% vs -20.77% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.31%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024